ExodusPoint Capital Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
ExodusPoint Capital Management's ORGO Position: Q3 2026 in Review
ExodusPoint Capital Management sold out of Organogenesis Holdings (ORGO) in Q3 2026, closing a stake of 228,834 shares — an estimated $556K sold.
ExodusPoint Capital Management first reported a position in ORGO in Q2 2021 and held it in 11 quarters. The position peaked at $3.3M in Q2 2023. 123 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.
- ExodusPoint Capital Management reported no remaining Organogenesis Holdings position as of Q3 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 228,834 Organogenesis Holdings shares in Q3 2026, an estimated $556K.
- ExodusPoint Capital Management first reported a position in Organogenesis Holdings in Q2 2021 and held it in 11 quarters.
- ExodusPoint Capital Management's Organogenesis Holdings position peaked at $3.3M in Q2 2023.
- 123 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.